HHS to pharmacies: Ensure patients aren’t overcharged for Paxlovid

In a Feb. 5 meeting with retail pharmacy CEOs, HHS Secretary Xavier Becerra stressed that patients should not be paying the full list price or high copays for Pfizer’s Paxlovid drug.